-
Study aim
-
The Primary Objective is to compare the rate of Extubation Failure in Premature Infants Receiving High-Pressure (8–10 cmH₂O) versus low-Pressure (6–8 cmH₂O) nCPAP.
-
Design
-
A randomized, parallel-group clinical trial with blinding of outcome assessor and statistician. Randomization will be performed using block randomization (with block sizes of 4 or 6), and allocation concealment will be achieved using sequentially numbered, sealed, opaque envelopes (SNOSE).
-
Settings and conduct
-
A randomized clinical trial on premature infants comparing extubation failure rates between two groups receiving high-pressure (8–10 cmH₂O) versus low-pressure (6–8 cmH₂O) nCPAP. Primary outcome: Extubation failure within 7 days. Study setting: NICU of Afzalipour Hospital, Kerman.
-
Participants/Inclusion and exclusion criteria
-
Inclusion: Preterm infants with gestational age less than 37 weeks, hospitalized in the NICU, receiving invasive mechanical ventilation, candidates for first-time Extubation, with parental informed consent.
Exclusion: Parental refusal, congenital or genetic anomalies affecting respiration, lack of ongoing intensive care provision.
-
Intervention groups
-
Group 1: Receives high-pressure nCPAP (8–10 cmH₂O) - Intervention Group.
Group 2: Receives low/standard-pressure nCPAP (6–8 cmH₂O) - Control Group.
Both groups receive surfactant and are followed for 7 days for extubation failure.
-
Main outcome variables
-
Primary Outcome: Extubation failure within 7 days post-extubation.
Definition: Presence of at least one of the following criteria in infants receiving maximum allowable nCPAP pressure: 1) FiO₂ requirement ≥ 0.2 above pre-extubation level, 2) pH < 7.20 and PCO₂ > 60 mmHg, 3) Recurrent apnea (more than one episode requiring PPV in 24 hours or ≥ 6 episodes requiring stimulation in 6 hours), 4) Urgent need for re-intubation.